JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizuka, H.
Right arrow Articles by Sugiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizuka, H.
Right arrow Articles by Sugiyama, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Vol. 280, Issue 3, 1304-1311, 1997

Temocaprilat, a Novel Angiotensin-Converting Enzyme Inhibitor, is Excreted in Bile via an ATP-dependent Active Transporter (cMOAT) That is Deficient in Eisai Hyperbilirubinemic Mutant Rats (EHBR)

Hitoshi Ishizuka, Kumiko Konno, Hideo Naganuma, Kunihiro Sasahara, Yukinori Kawahara, Kayoko Niinuma, Hiroshi Suzuki and Yuichi Sugiyama

Analytical and Metabolic Research Laboratories (H.I., K.K., H.N., K.S., Y.K.), Sankyo Co., Ltd., Tokyo, Japan and the Faculty of Pharmaceutical Sciences (K.N., H.S., Y.S.), The University of Tokyo, Tokyo, Japan

Temocapril · HCl (alpha -{(2S,6R)-6-[(1S)-1-ethoxy-carbonyl-3-phenyl-propyl]amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4yl}acetic acid hydrochloride) is a novel prodrug of an angiotensin-converting enzyme (ACE) inhibitor. Unlike many other ACE inhibitors, its pharmacologically active metabolite,temocaprilat, is excreted predominantly in bile. To investigate the mechanism for the biliary excretion of temocaprilat, we performed in vivo and in vitro experiments using mutant Eisai hyperbilirubinemic rats EHBR) whose canalicular multispecific organic anion transporter (cMOAT) is hereditarily defective. Biliary clearance of temocaprilat after i.v. administration of [14C]temocapril · HCl (1.0 mg/kg) in EHBR was significantly lower than that in Sprague-Dawley rats (5.00 ml/min/kg for Sprague-Dawley rats vs. 0.25 ml/min/kg for EHBR). The uptake of temocaprilat into canalicular membrane vesicles (CMVs) prepared from Sprague-Dawley rats was stimulated in the presence of ATP, whereas little stimulation was observed in CMVs from EHBR. The initial uptake rate of ATP-dependent transport of temocaprilat showed saturation kinetics; we obtained an apparent Vmax value of 1.14 nmol/min/mg protein and a Km value 92.5 µM. ATP-dependent transport of temocaprilat was competitively inhibited by 2,4-dinitrophenyl-S-glutathione, a typical substrate for cMOAT with an inhibition constant (Ki) of 25.8 µM. The Km value for the uptake of 2,4-dinitrophenyl-S-glutathione into CMVs (Km = 29.6 µM) was consistent with this Ki value. In addition, the ATP-dependent uptake of 2,4-dinitrophenyl-S-glutathione was inhibited by temocaprilat in a concentration-dependent manner. Active forms of some ACE inhibitors (benazepril, cilazapril, delapril, enalapril and imidapril) did not affect the transport of temocaprilat into CMVs even at concentrations as high as 200 µM. These data suggest that temocaprilat is effectively excreted in bile via cMOAT that is deficient in EHBR and that many of other ACE inhibitors have low affinity for cMOAT.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. Watanabe, K. Maeda, T. Kondo, H. Nakayama, S. Horita, H. Kusuhara, and Y. Sugiyama
Prediction of the Hepatic and Renal Clearance of Transporter Substrates in Rats Using in Vitro Uptake Experiments
Drug Metab. Dispos., July 1, 2009; 37(7): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Hu, K. E. Sampson, B. R. Heyde, K. M. Mandrell, N. Li, A. Zutshi, and Y. Lai
Saturation of Multidrug-Resistant Protein 2 (Mrp2/Abcc2)-Mediated Hepatobiliary Secretion: Nonlinear Pharmacokinetics of a Heterocyclic Compound in Rats after Intravenous Bolus Administration
Drug Metab. Dispos., April 1, 2009; 37(4): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Abe, A. S. Bridges, and K. L. R. Brouwer
Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors
Drug Metab. Dispos., March 1, 2009; 37(3): 447 - 452.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Liu, Y. Cui, A. Y. Chung, Y. Shitara, Y. Sugiyama, D. Keppler, and K. S. Pang
Vectorial Transport of Enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in Rat and Human Livers
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. Nishiya, H. Kataoka, K. Mori, M. Goto, T. Sugawara, and K. Furuhama
Tienilic Acid Enhances Hyperbilirubinemia in Eisai Hyperbilirubinuria Rats through Hepatic Multidrug Resistance-Associated Protein 3 and Heme Oxygenase-1 Induction
Toxicol. Sci., June 1, 2006; 91(2): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Imai, M. Imoto, H. Sakamoto, and M. Hashimoto
IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION
Drug Metab. Dispos., August 1, 2005; 33(8): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Ninomiya, K. Ito, and T. Horie
FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2
Drug Metab. Dispos., February 1, 2005; 33(2): 225 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Fukunari, K. Okamoto, T. Nishino, B. T. Eger, E. F. Pai, M. Kamezawa, I. Yamada, and N. Kato
Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic Acid]: A Potent Xanthine Oxidoreductase Inhibitor with Hepatic Excretion
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Sasaki, H. Suzuki, J. Aoki, K. Ito, P. J. Meier, and Y. Sugiyama
Prediction of in Vivo Biliary Clearance from the in Vitro Transcellular Transport of Organic Anions across a Double-Transfected Madin-Darby Canine Kidney II Monolayer Expressing Both Rat Organic Anion Transporting Polypeptide 4 and Multidrug Resistance Associated Protein 2
Mol. Pharmacol., September 1, 2004; 66(3): 450 - 459.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama
Impact of Drug Transporter Studies on Drug Discovery and Development
Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kirima, K. Tsuchiya, H. Sei, T. Hasegawa, M. Shikishima, Y. Motobayashi, K. Morita, M. Yoshizumi, and T. Tamaki
Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H589 - H596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. F. Fromm, H.-M. Kauffmann, P. Fritz, O. Burk, H. K. Kroemer, R. W. Warzok, M. Eichelbaum, W. Siegmund, and D. Schrenk
The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Am. J. Pathol., November 1, 2000; 157(5): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel
Molecular pharmacology of renal organic anion transporters
Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Ishizuka, K. Konno, T. Shiina, H. Naganuma, K. Nishimura, K. Ito, H. Suzuki, and Y. Sugiyama
Species Differences in the Transport Activity for Organic Anions across the Bile Canalicular Membrane
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1324 - 1330.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Niinuma, Y. Kato, H. Suzuki, C. A. Tyson, V. Weizer, J. E. Dabbs, R. Froehlich, C. E. Green, and Y. Sugiyama
Primary active transport of organic anions on bile canalicular membrane in humans
Am J Physiol Gastrointest Liver Physiol, May 1, 1999; 276(5): G1153 - G1164.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Homma, H. Suzuki, H. Kusuhara, M. Naito, T. Tsuruo, and Y. Sugiyama
High-Affinity Efflux Transport System for Glutathione Conjugates on the Luminal Membrane of a Mouse Brain Capillary Endothelial Cell Line (MBEC4)
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 198 - 203.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Ishizuka, K. Konno, H. Naganuma, K. Nishimura, H. Kouzuki, H. Suzuki, B. Stieger, P. J. Meier, and Y. Sugiyama
Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 37 - 42.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. Hirohashi, H. Suzuki, K. Ito, K. Ogawa, K. Kume, T. Shimizu, and Y. Sugiyama
Hepatic Expression of Multidrug Resistance-Associated Protein-Like Proteins Maintained in Eisai Hyperbilirubinemic Rats
Mol. Pharmacol., June 1, 1998; 53(6): 1068 - 1075.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Ito, H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama
Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver
J. Biol. Chem., January 16, 1998; 273(3): 1684 - 1688.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.